ATE281467T1 - Verbindungen mit wachstumshormon-freisetzenden eigenschaften - Google Patents

Verbindungen mit wachstumshormon-freisetzenden eigenschaften

Info

Publication number: ATE281467T1
Authority: AT; Austria
Prior art keywords: compounds; growth hormone; hormone releasing; releasing properties; properties
Prior art date: 1998-01-16

Application number

AT99900877T

Other languages

English (en)

Inventor

Michael Ankersen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-16

Filing date

1999-01-15

Publication date

2004-11-15

1999-01-15 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE281467T1 publication Critical patent/ATE281467T1/de

Links

102000018997 Growth Hormone Human genes 0.000 title abstract 2
108010051696 Growth Hormone Proteins 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 title abstract 2
239000000122 growth hormone Substances 0.000 title abstract 2
230000003578 releasing effect Effects 0.000 title 1
230000007812 deficiency Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Crystallography & Structural Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT99900877T 1998-01-16 1999-01-15 Verbindungen mit wachstumshormon-freisetzenden eigenschaften ATE281467T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK5698		1998-01-16
DK79998		1998-06-15
PCT/DK1999/000021 WO1999036431A1 (en)	1998-01-16	1999-01-15	Compounds with growth hormone releasing properties

Publications (1)

Publication Number	Publication Date
ATE281467T1 true ATE281467T1 (de)	2004-11-15

Family

ID=26063207

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT04078016T ATE470671T1 (de)	1998-01-16	1999-01-15	Verbindungen mit wachstumshormon-freisetzender eigenschaft
AT99900877T ATE281467T1 (de)	1998-01-16	1999-01-15	Verbindungen mit wachstumshormon-freisetzenden eigenschaften

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT04078016T ATE470671T1 (de)	1998-01-16	1999-01-15	Verbindungen mit wachstumshormon-freisetzender eigenschaft

Country Status (15)

Country	Link
EP (2)	EP1047709B1 (de)
JP (1)	JP4382279B2 (de)
KR (1)	KR20010034198A (de)
CN (1)	CN1288467A (de)
AT (2)	ATE470671T1 (de)
AU (1)	AU766305B2 (de)
BR (1)	BR9906975A (de)
CA (1)	CA2318558A1 (de)
DE (1)	DE69921611T2 (de)
HU (1)	HUP0100777A3 (de)
IL (1)	IL137007A0 (de)
NO (1)	NO20003629L (de)
PL (1)	PL341707A1 (de)
TW (1)	TW589325B (de)
WO (1)	WO1999036431A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020111461A1 (en)	1999-05-21	2002-08-15	Todd C. Somers	Low molecular weight peptidomimetic growth hormone secretagogues
UA73530C2 (uk) *	1999-11-10	2005-08-15	Ново Нордіск А/С	Сполука з властивостями вивільнювати гормон росту
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
US7825138B2 (en) *	2004-06-29	2010-11-02	Helsinn Therapeutics (U.S.), Inc.	Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CN101657436A (zh)	2007-02-09	2010-02-24	特兰齐姆制药公司	大环生长素释放肽受体调节剂及其使用方法
CN108129357B (zh) *	2016-12-01	2021-12-21	上海医药工业研究院	阿拉莫林中间体的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8005121A (nl) *	1979-09-20	1981-03-24	Erba Farmitalia	Biologisch actieve peptiden.
JPS58501861A (ja)	1981-12-28	1983-11-04	ベツクマン・インストルメンツ・インコ−ポレ−テツド	下垂体成長ホルモン放出活性を有する合成ペプチド
US4839344A (en)	1987-06-12	1989-06-13	Eastman Kodak Company	Polypeptide compounds having growth hormone releasing activity
DE68912775T2 (de)	1988-05-11	1994-06-30	Polygen Holding Corp	Polypeptid-verbindungen mit hormonwachstumsbefreiender wirkung.
IT1240643B (it)	1990-05-11	1993-12-17	Mediolanum Farmaceutici Spa	Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
IL98910A0 (en)	1990-07-24	1992-07-15	Polygen Holding Corp	Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en)	1991-08-22	1997-09-02	Administrators Of The Tulane Educational Fund	Polypeptide analogues having growth hormone releasing activity
US5578593A (en)	1992-12-11	1996-11-26	Merck & Co., Inc.	Spiro piperidines and homologs promote release of growth hormone
WO1995014666A1 (en)	1993-11-24	1995-06-01	Merck & Co., Inc.	Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
WO1995017423A1 (en)	1993-12-23	1995-06-29	Novo Nordisk A/S	Compounds with growth hormone releasing properties
AU683121B2 (en)	1993-12-23	1997-10-30	Novo Nordisk A/S	Compounds with growth hormone releasing properties
US5777112A (en)	1994-06-13	1998-07-07	Merck & Co., Inc	Piperazine compounds promote release of growth hormone
AU3128195A (en)	1994-07-20	1996-02-16	Merck & Co., Inc.	Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
US5767118A (en)	1994-10-26	1998-06-16	Merck & Co., Inc.	4-Heterocyclic peperidines promote release of growth hormone
US5798337A (en)	1994-11-16	1998-08-25	Genentech, Inc.	Low molecular weight peptidomimetic growth hormone secretagogues
ID18218A (id)	1995-01-27	1998-03-19	Novo Nordisk As	Senyawa dengan sifat-sifat pelepas hormon pertumbuhan
US5559128A (en)	1995-04-18	1996-09-24	Merck & Co., Inc.	3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en)	1995-05-08	1996-11-14	Pfizer, Inc.	Dipeptides which promote release of growth hormone
FI974368A7 (fi)	1995-05-29	1997-11-28	Pfizer	Kasvuhormonin vapautumista edistäviä dipeptidejä
AU711104B2 (en)	1995-06-22	1999-10-07	Novo Nordisk A/S	Compounds with growth hormone releasing properties
EP0761219A1 (de)	1995-08-21	1997-03-12	Eli Lilly And Company	2-Acylaminopropanamine zur Förderung der Wachstumshormon-Sekretion
WO1997006803A1 (en)	1995-08-21	1997-02-27	Eli Lilly And Company	2-acylaminopropanamides as growth hormone secretagogues
EP0766966A3 (de)	1995-09-08	2001-02-28	Eli Lilly And Company	Methode zur Behandlung der Insulinresistenz
AU7169696A (en)	1995-09-26	1997-04-17	Merck & Co., Inc.	3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone
IT1277113B1 (it)	1995-12-20	1997-11-04	Romano Deghenghi	Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
CZ195098A3 (cs) *	1995-12-22	1998-10-14	Novo Nordisk A/S	Sloučeniny uvolňující růstový hormon
TW432073B (en)	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
WO1997034604A1 (en)	1996-03-21	1997-09-25	Merck & Co., Inc.	4-spiroindoline piperidines promote release of growth hormone
EP1005484A1 (de) *	1997-06-20	2000-06-07	Novo Nordisk A/S	Verbindungen mit wachstumshormon freisetzenden eigenschaften

1999
- 1999-01-15 HU HU0100777A patent/HUP0100777A3/hu unknown
- 1999-01-15 CN CN99802165A patent/CN1288467A/zh active Pending
- 1999-01-15 AT AT04078016T patent/ATE470671T1/de not_active IP Right Cessation
- 1999-01-15 PL PL99341707A patent/PL341707A1/xx not_active Application Discontinuation
- 1999-01-15 EP EP99900877A patent/EP1047709B1/de not_active Expired - Lifetime
- 1999-01-15 KR KR1020007007835A patent/KR20010034198A/ko not_active Withdrawn
- 1999-01-15 AU AU20465/99A patent/AU766305B2/en not_active Ceased
- 1999-01-15 CA CA002318558A patent/CA2318558A1/en not_active Abandoned
- 1999-01-15 JP JP2000540146A patent/JP4382279B2/ja not_active Expired - Lifetime
- 1999-01-15 EP EP04078016A patent/EP1506969B1/de not_active Expired - Lifetime
- 1999-01-15 WO PCT/DK1999/000021 patent/WO1999036431A1/en not_active Ceased
- 1999-01-15 AT AT99900877T patent/ATE281467T1/de not_active IP Right Cessation
- 1999-01-15 IL IL13700799A patent/IL137007A0/xx unknown
- 1999-01-15 BR BR9906975-0A patent/BR9906975A/pt not_active IP Right Cessation
- 1999-01-15 DE DE69921611T patent/DE69921611T2/de not_active Expired - Lifetime
- 1999-01-26 TW TW088101140A patent/TW589325B/zh active
2000
- 2000-07-14 NO NO20003629A patent/NO20003629L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1999036431A1 (en)	1999-07-22
DE69921611D1 (de)	2004-12-09
EP1047709B1 (de)	2004-11-03
CA2318558A1 (en)	1999-07-22
NO20003629L (no)	2000-09-15
PL341707A1 (en)	2001-04-23
EP1506969B1 (de)	2010-06-09
JP2002509156A (ja)	2002-03-26
AU2046599A (en)	1999-08-02
TW589325B (en)	2004-06-01
HUP0100777A2 (hu)	2001-08-28
WO1999036431A9 (en)	2000-07-27
EP1506969A1 (de)	2005-02-16
NO20003629D0 (no)	2000-07-14
AU766305B2 (en)	2003-10-16
DE69921611T2 (de)	2005-11-03
CN1288467A (zh)	2001-03-21
JP4382279B2 (ja)	2009-12-09
HUP0100777A3 (en)	2001-12-28
EP1047709A1 (de)	2000-11-02
ATE470671T1 (de)	2010-06-15
IL137007A0 (en)	2001-06-14
BR9906975A (pt)	2000-10-17
KR20010034198A (ko)	2001-04-25

Legal Events

Date	Code	Title	Description
2005-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE344063T1 (de)	2006-11-15	Beschichtete medizinische geräte
ATE248837T1 (de)	2003-09-15	Chinuclidin-acrylamide
MA23533A1 (fr)	1995-12-31	Formes posologiques d'azithromycine
TR199701212T1 (xx)	1998-03-21	�drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
DK1137410T3 (da)	2006-12-27	Hidtil ukendte 4-dedimethylaminotetracyclinderivater
DE69623899D1 (de)	2002-10-31	Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
DE69941255D1 (de)	2009-09-24	Verbindungen mit wachstumshormon freisetzenden eigenschaften
ATE231131T1 (de)	2003-02-15	Verbindungen mit wachtumshormon freisetzenden eigenschaften
DK0503887T3 (da)	1996-09-16	Fremme af sårheling med 15-ketoprostaglandinforbindelser
DE69318821D1 (de)	1998-07-02	Katheter zur Versorgung des Penis mit Medikamenten
EP0467564A3 (en)	1992-07-08	Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE281467T1 (de)	2004-11-15	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ATE500269T1 (de)	2011-03-15	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ES2102772T3 (es)	1997-08-01	Compuesto citotoxico y antiviral.
ID25478A (id)	2000-10-05	Agonis 5-ht1f
DE19983519T1 (de)	2001-09-13	Vorrichtung zur Wärmebehandlung von Körpergewebe
ATE182594T1 (de)	1999-08-15	Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität
PT1027891E (pt)	2005-04-29	Antagonista de neuropeptido y
NO20012169L (no)	2001-05-02	Forbindelser med veksthormonfrigjörende egenskaper
NO945094D0 (no)	1994-12-30	Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer
ATE90565T1 (de)	1993-07-15	Behandlung des schocks mit cyclodextrin und dessen derivaten.
ATE80800T1 (de)	1992-10-15	Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.